Heart Line Hospital & Research Institute Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
About Heart Line Hospital & Research Institute
Heart Line Hospital & Research Institute Private Limited (HLHRIPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 March 2020 (Four years and 11 months 1 days old ). Its registered office is in Birbhum, West Bengal, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Bivas Banerjee, Madhumita Banerjee, Sunil Banerjee, and Two other members serve as directors at the Company.
Company Details
-
Location
Birbhum, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100WB2020PTC236832
-
Company No.
236832
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Mar 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Heart Line Hospital & Research Institute?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bivas Banerjee
|
Director | 06-Mar-2020 | Current |
|
Madhumita Banerjee
|
Director | 06-Mar-2020 | Current |
|
Sunil Banerjee
|
Director | 06-Mar-2020 | Current |
|
Salja Banerjee
|
Director | 06-Mar-2020 | Current |
|
Subhadip Raptan
|
Additional Director | 20-Oct-2021 | Current |
Financial Performance of Heart Line Hospital & Research Institute.
Enhance accessibility to Heart Line Hospital & Research Institute's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Heart Line Hospital & Research Institute?
Unlock access to Heart Line Hospital & Research Institute's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Heart Line Hospital & Research Institute?
Unlock and access historical data on people associated with Heart Line Hospital & Research Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Heart Line Hospital & Research Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Heart Line Hospital & Research Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
